Growth Metrics

Amneal Pharmaceuticals (AMRX) Change in Intangibles (2017 - 2025)

Historic Change in Intangibles for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $7.4 million.

  • Amneal Pharmaceuticals' Change in Intangibles rose 10594.44% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 6137.26%. This contributed to the annual value of $14.6 million for FY2024, which is 3456.32% down from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Change in Intangibles stood at $7.4 million for Q3 2025, which was up 10594.44% from $900000.0 recorded in Q2 2025.
  • Amneal Pharmaceuticals' Change in Intangibles' 5-year high stood at $31.8 million during Q3 2022, with a 5-year trough of $338000.0 in Q1 2023.
  • For the 5-year period, Amneal Pharmaceuticals' Change in Intangibles averaged around $6.2 million, with its median value being $1.2 million (2021).
  • Within the past 5 years, the most significant YoY rise in Amneal Pharmaceuticals' Change in Intangibles was 276982.25% (2024), while the steepest drop was 9698.49% (2024).
  • Over the past 5 years, Amneal Pharmaceuticals' Change in Intangibles (Quarter) stood at $1.2 million in 2021, then soared by 2550.0% to $31.8 million in 2022, then crashed by 37.42% to $19.9 million in 2023, then crashed by 96.98% to $600000.0 in 2024, then surged by 1135.67% to $7.4 million in 2025.
  • Its Change in Intangibles was $7.4 million in Q3 2025, compared to $900000.0 in Q2 2025 and $4.2 million in Q1 2025.